Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies.

COVID-19 Community engagement Deprivation Employment Health inequalities Partnership working

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 06 2023
Historique:
received: 03 10 2022
accepted: 20 04 2023
medline: 23 6 2023
pubmed: 22 6 2023
entrez: 21 6 2023
Statut: epublish

Résumé

UK local authorities that experienced sustained high levels of COVID-19 between 1st March 2020 and 28th February 2021 were described by the UK Scientific Advisory Group for Emergencies as areas of enduring prevalence. This research was carried out in order to examine the views of local authority Directors of Public Health, who played a crucial role in the local response to COVID-19, on reasons for sustained high levels of prevalence in some areas, alongside an investigation of the mitigation strategies that they implemented during the course of the pandemic. Interviews were conducted with Directors of Public Health in 19 local authority areas across England, between July and November 2021. This included nine areas identified as areas of enduring prevalence and ten 'comparison' areas. The outcomes of this study suggests that the geographical differences in prevalence rates are strongly influenced by health inequalities. Structural factors including deprivation, employment, and housing, due to their disproportionate impact on specific groups, converged with demographic factors, including ethnicity and age, and vaccination rates, and were identified as the main drivers of enduring prevalence. There are key differences in these drivers both within and, to a lesser extent, between local authorities. Other than these structural barriers, no major differences in facilitators or barriers to COVID-19 mitigation were identified between areas of varying prevalence. The main features of successful mitigation strategies were a locally tailored approach and partnership working involving local authority departments working with local health, community, voluntary and business organisations. This study is the first to add the voices of Directors of Public Health, who played a crucial role in the local COVID-19 response. Areas of enduring prevalence existed during the pandemic which were caused by a complex mix of structural factors related to inequalities. Participants advised that more research is needed on the effectiveness of mitigation strategies and other measures to reduce the impact of structural inequalities, to better understand the factors that drive prevalence. This would include an assessment of how these factors combine to predict transmission and how this varies between different areas.

Sections du résumé

BACKGROUND
UK local authorities that experienced sustained high levels of COVID-19 between 1st March 2020 and 28th February 2021 were described by the UK Scientific Advisory Group for Emergencies as areas of enduring prevalence. This research was carried out in order to examine the views of local authority Directors of Public Health, who played a crucial role in the local response to COVID-19, on reasons for sustained high levels of prevalence in some areas, alongside an investigation of the mitigation strategies that they implemented during the course of the pandemic.
METHODS
Interviews were conducted with Directors of Public Health in 19 local authority areas across England, between July and November 2021. This included nine areas identified as areas of enduring prevalence and ten 'comparison' areas.
RESULTS
The outcomes of this study suggests that the geographical differences in prevalence rates are strongly influenced by health inequalities. Structural factors including deprivation, employment, and housing, due to their disproportionate impact on specific groups, converged with demographic factors, including ethnicity and age, and vaccination rates, and were identified as the main drivers of enduring prevalence. There are key differences in these drivers both within and, to a lesser extent, between local authorities. Other than these structural barriers, no major differences in facilitators or barriers to COVID-19 mitigation were identified between areas of varying prevalence. The main features of successful mitigation strategies were a locally tailored approach and partnership working involving local authority departments working with local health, community, voluntary and business organisations.
CONCLUSIONS
This study is the first to add the voices of Directors of Public Health, who played a crucial role in the local COVID-19 response. Areas of enduring prevalence existed during the pandemic which were caused by a complex mix of structural factors related to inequalities. Participants advised that more research is needed on the effectiveness of mitigation strategies and other measures to reduce the impact of structural inequalities, to better understand the factors that drive prevalence. This would include an assessment of how these factors combine to predict transmission and how this varies between different areas.

Identifiants

pubmed: 37344781
doi: 10.1186/s12889-023-15723-7
pii: 10.1186/s12889-023-15723-7
pmc: PMC10286421
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1203

Informations de copyright

© 2023. The Author(s).

Références

Eur J Public Health. 2020 Feb 1;30(1):132-141
pubmed: 30597009
J Epidemiol Community Health. 2021 Aug;75(8):729-734
pubmed: 33542030
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Occup Environ Med. 2022 Jul;79(7):433-441
pubmed: 34965981
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200280
pubmed: 34053251
Health Place. 2021 Jan;67:102460
pubmed: 33418438
Appl Spat Anal Policy. 2022;15(3):621-646
pubmed: 34493948

Auteurs

Catherine Lewis (C)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, England. catherine.lewis@manchester.ac.uk.

Sheena Johnson (S)

Alliance Manchester Business School, University of Manchester, Manchester, England.

Angelique Hartwig (A)

Alliance Manchester Business School, University of Manchester, Manchester, England.

Janet Ubido (J)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, England.

Anna Coleman (A)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, England.

Nicola Gartland (N)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, England.

Atiya Kamal (A)

Birmingham City University, Birmingham, England.

Amit Gaokar (A)

Rochdale Borough Council, Manchester, England.

Christopher J Armitage (CJ)

Manchester Centre for Health Psychology, University of Manchester, Manchester, England.

David Fishwick (D)

Health and Safety Executive (HSE), Liverpool, England.

Martie van Tongeren (M)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH